Esterhuizen M, Park C, Kim Y, Kim T, Yoon H, Andres F
Front Mol Biosci. 2023; 10:1274221.
PMID: 38053578
PMC: 10694350.
DOI: 10.3389/fmolb.2023.1274221.
Zhou M, Gan X, Ren Y, Chen Q, Yang Y, Weng Z
BMC Cancer. 2023; 23(1):743.
PMID: 37568077
PMC: 10416444.
DOI: 10.1186/s12885-023-10964-6.
Zhang K, Li Y, Kong X, Lei C, Yang H, Wang N
Front Oncol. 2023; 13:1195885.
PMID: 37197416
PMC: 10183570.
DOI: 10.3389/fonc.2023.1195885.
Kosykh A, Tereshina M, Gurskaya N
Int J Mol Sci. 2023; 24(9).
PMID: 37175601
PMC: 10178616.
DOI: 10.3390/ijms24097895.
Carbonell-M B, Zapata Cardona J, Delgado J
Front Cell Dev Biol. 2022; 10:921520.
PMID: 36092695
PMC: 9458980.
DOI: 10.3389/fcell.2022.921520.
The long non-coding RNA GHSROS reprograms prostate cancer cell lines toward a more aggressive phenotype.
Thomas P, Jeffery P, Gahete M, Whiteside E, Walpole C, Maugham M
PeerJ. 2021; 9:e10280.
PMID: 33585078
PMC: 7860111.
DOI: 10.7717/peerj.10280.
Endothelium-Derived Extracellular Vesicles Associate with Poor Prognosis in Metastatic Colorectal Cancer.
Nanou A, Mol L, Coumans F, Koopman M, Punt C, Terstappen L
Cells. 2020; 9(12).
PMID: 33333805
PMC: 7765205.
DOI: 10.3390/cells9122688.
Dysregulation of SPRR3/miR-876-3p Axis Contributes to Tumorigenesis in Non-Small-Cell Lung Cancer.
Li Q, Wang Y, Hu R, Yang G
Onco Targets Ther. 2020; 13:2411-2419.
PMID: 32273714
PMC: 7106992.
DOI: 10.2147/OTT.S245422.
MUC1 oncoprotein mitigates ER stress via CDA-mediated reprogramming of pyrimidine metabolism.
Olou A, King R, Yu F, Singh P
Oncogene. 2020; 39(16):3381-3395.
PMID: 32103170
PMC: 7165067.
DOI: 10.1038/s41388-020-1225-4.
LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2 transcription.
Xiu B, Chi Y, Liu L, Chi W, Zhang Q, Chen J
Mol Cancer. 2019; 18(1):187.
PMID: 31856843
PMC: 6921600.
DOI: 10.1186/s12943-019-1115-y.
Impact of Heat Shock Protein 90 Inhibition on the Proteomic Profile of Lung Adenocarcinoma as Measured by Two-Dimensional Electrophoresis Coupled with Mass Spectrometry.
Marrugal A, Ferrer I, Pastor M, Ojeda L, Quintanal-Villalonga A, Carnero A
Cells. 2019; 8(8).
PMID: 31370342
PMC: 6721529.
DOI: 10.3390/cells8080806.
Leveraging the Role of the Metastatic Associated Protein Anterior Gradient Homologue 2 in Unfolded Protein Degradation: A Novel Therapeutic Biomarker for Cancer.
Alsereihi R, Schulten H, Bakhashab S, Saini K, Al-Hejin A, Hussein D
Cancers (Basel). 2019; 11(7).
PMID: 31247903
PMC: 6678570.
DOI: 10.3390/cancers11070890.
FOXA1 is Prognostic of Triple Negative Breast Cancers by Transcriptionally Suppressing and .
Dai X, Cheng H, Chen X, Li T, Zhang J, Jin G
Int J Biol Sci. 2019; 15(5):1030-1041.
PMID: 31182923
PMC: 6535797.
DOI: 10.7150/ijbs.31009.
New Insights into the Role of Endoplasmic Reticulum Stress in Breast Cancer Metastasis.
Han C, Wan F
J Breast Cancer. 2019; 21(4):354-362.
PMID: 30607156
PMC: 6310719.
DOI: 10.4048/jbc.2018.21.e51.
High AGR2 protein is a feature of low grade endometrial cancer cells.
Kamal A, Valentijn A, Barraclough R, Rudland P, Rahmatalla N, Martin-Hirsch P
Oncotarget. 2018; 9(59):31459-31472.
PMID: 30140383
PMC: 6101135.
DOI: 10.18632/oncotarget.25838.
Suppression of AGR2 in a TGF-β-induced Smad regulatory pathway mediates epithelial-mesenchymal transition.
Sommerova L, Ondrouskova E, Vojtesek B, Hrstka R
BMC Cancer. 2017; 17(1):546.
PMID: 28810836
PMC: 5557473.
DOI: 10.1186/s12885-017-3537-5.
Tumor-secreted anterior gradient-2 binds to VEGF and FGF2 and enhances their activities by promoting their homodimerization.
Guo H, Zhu Q, Yu X, Merugu S, Mangukiya H, Smith N
Oncogene. 2017; 36(36):5098-5109.
PMID: 28481872
DOI: 10.1038/onc.2017.132.
AGR2 promotes the proliferation, migration and regulates epithelial-mesenchymal transition in salivary adenoid cystic carcinoma.
Ma S, Mao L, Deng W, Li Y, Bu L, Yu G
Am J Transl Res. 2017; 9(2):507-519.
PMID: 28337279
PMC: 5340686.
AGR2 is associated with gastric cancer progression and poor survival.
Zhang J, Jin Y, Xu S, Zheng J, Zhang Q, Wang Y
Oncol Lett. 2016; 11(3):2075-2083.
PMID: 26998125
PMC: 4774612.
DOI: 10.3892/ol.2016.4160.
High expression of AGR2 in lung cancer is predictive of poor survival.
Alavi M, Mah V, Maresh E, Bagryanova L, Horvath S, Chia D
BMC Cancer. 2015; 15:655.
PMID: 26445321
PMC: 4596313.
DOI: 10.1186/s12885-015-1658-2.